NEW ENGLAND BIOLABS, INC. has sponsored the creation of one or more 401k plans.
Submission information for form 5500 for 401k plan NEW ENGLAND BIOLABS, INC. VOTING STOCK OWNERSHIP PLAN
401k plan membership statisitcs for NEW ENGLAND BIOLABS, INC. VOTING STOCK OWNERSHIP PLAN
| Measure | Date | Value |
|---|
| 2022 : NEW ENGLAND BIOLABS, INC. VOTING STOCK OWNERSHIP PLAN 2022 401k financial data |
|---|
| Unrealized appreciation/depreciation of other (non real estate) assets | 2022-09-30 | $-209,094,660 |
| Total unrealized appreciation/depreciation of assets | 2022-09-30 | $-209,094,660 |
| Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities) | 2022-09-30 | $342,101,601 |
| Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities) | 2022-09-30 | $0 |
| Total income from all sources (including contributions) | 2022-09-30 | $-181,690,011 |
| Total loss/gain on sale of assets | 2022-09-30 | $0 |
| Total of all expenses incurred | 2022-09-30 | $396,074,519 |
| Benefit payments and payments to participlants,beneficiaries,insurance carriers and others | 2022-09-30 | $396,074,519 |
| Total contributions o plan (from employers,participants, others, non cash contrinutions) | 2022-09-30 | $10,984,001 |
| Value of total assets at end of year | 2022-09-30 | $656,144,490 |
| Value of total assets at beginning of year | 2022-09-30 | $891,807,419 |
| Total of administrative expenses incurred including professional, contract, advisory and management fees | 2022-09-30 | $0 |
| Total interest from all sources | 2022-09-30 | $17,172 |
| Total dividends received (eg from common stock, registered investment company shares) | 2022-09-30 | $27,569,357 |
| Has a resolution to terminate the plan been adopted during the plan year or any prior plan year | 2022-09-30 | No |
| Was this plan covered by a fidelity bond | 2022-09-30 | Yes |
| Value of fidelity bond cover | 2022-09-30 | $1,000,000 |
| If this is an individual account plan, was there a blackout period | 2022-09-30 | No |
| Were there any nonexempt tranactions with any party-in-interest | 2022-09-30 | No |
| Other liabilities (not benefit claims, operating payabales oe acquisition indebtedness) at end of year | 2022-09-30 | $342,101,601 |
| Other income not declared elsewhere | 2022-09-30 | $-11,165,881 |
| Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser | 2022-09-30 | No |
| Value of net income/loss | 2022-09-30 | $-577,764,530 |
| Value of net assets at end of year (total assets less liabilities) | 2022-09-30 | $314,042,889 |
| Value of net assets at beginning of year (total assets less liabilities) | 2022-09-30 | $891,807,419 |
| Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond) | 2022-09-30 | No |
| Were any loans by the plan or fixed income obligations due to the plan in default | 2022-09-30 | No |
| Were any leases to which the plan was party in default or uncollectible | 2022-09-30 | No |
| Value of interest bearing cash (including money market accounts and certificates of deposits) at end of year | 2022-09-30 | $674,468 |
| Interest earned from interest bearing cash (including money market accounts and certificates of deposit) | 2022-09-30 | $17,172 |
| Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets | 2022-09-30 | No |
| Was there a failure to transmit to the plan any participant contributions | 2022-09-30 | No |
| Has the plan failed to provide any benefit when due under the plan | 2022-09-30 | No |
| Contributions received in cash from employer | 2022-09-30 | $10,984,001 |
| Employer contributions (assets) at end of year | 2022-09-30 | $104,624 |
| Income. Dividends from common stock | 2022-09-30 | $27,569,357 |
| Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers | 2022-09-30 | $396,074,519 |
| Assets. Corporate common stocks other than exployer securities at end of year | 2022-09-30 | $655,365,398 |
| Assets. Corporate common stocks other than exployer securities at beginning of year | 2022-09-30 | $891,807,419 |
| Did the plan have assets held for investment | 2022-09-30 | Yes |
| Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser | 2022-09-30 | No |
| Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC | 2022-09-30 | No |
| Opinion of an independent qualified public accountant for this plan | 2022-09-30 | Unqualified |
| Accountancy firm name | 2022-09-30 | CARON & BLETZER |
| Accountancy firm EIN | 2022-09-30 | 043499945 |
| 2021 : NEW ENGLAND BIOLABS, INC. VOTING STOCK OWNERSHIP PLAN 2021 401k financial data |
|---|
| Unrealized appreciation/depreciation of other (non real estate) assets | 2021-09-30 | $557,190,637 |
| Total unrealized appreciation/depreciation of assets | 2021-09-30 | $557,190,637 |
| Total transfer of assets to this plan | 2021-09-30 | $345,425,977 |
| Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities) | 2021-09-30 | $0 |
| Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities) | 2021-09-30 | $0 |
| Total income from all sources (including contributions) | 2021-09-30 | $557,190,637 |
| Total loss/gain on sale of assets | 2021-09-30 | $0 |
| Total of all expenses incurred | 2021-09-30 | $10,809,195 |
| Benefit payments and payments to participlants,beneficiaries,insurance carriers and others | 2021-09-30 | $10,809,195 |
| Total contributions o plan (from employers,participants, others, non cash contrinutions) | 2021-09-30 | $0 |
| Value of total assets at end of year | 2021-09-30 | $891,807,419 |
| Value of total assets at beginning of year | 2021-09-30 | $0 |
| Total of administrative expenses incurred including professional, contract, advisory and management fees | 2021-09-30 | $0 |
| Total interest from all sources | 2021-09-30 | $0 |
| Total dividends received (eg from common stock, registered investment company shares) | 2021-09-30 | $0 |
| Was this plan covered by a fidelity bond | 2021-09-30 | Yes |
| Value of fidelity bond cover | 2021-09-30 | $1,000,000 |
| If this is an individual account plan, was there a blackout period | 2021-09-30 | No |
| Total value of distributions paid in property other than in cash, annuity contracts, or publicly traded employer securities | 2021-09-30 | $10,809,195 |
| Were there any nonexempt tranactions with any party-in-interest | 2021-09-30 | No |
| Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser | 2021-09-30 | No |
| Value of net income/loss | 2021-09-30 | $546,381,442 |
| Value of net assets at end of year (total assets less liabilities) | 2021-09-30 | $891,807,419 |
| Value of net assets at beginning of year (total assets less liabilities) | 2021-09-30 | $0 |
| Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond) | 2021-09-30 | No |
| Were any loans by the plan or fixed income obligations due to the plan in default | 2021-09-30 | No |
| Were any leases to which the plan was party in default or uncollectible | 2021-09-30 | No |
| Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets | 2021-09-30 | No |
| Was there a failure to transmit to the plan any participant contributions | 2021-09-30 | No |
| Has the plan failed to provide any benefit when due under the plan | 2021-09-30 | No |
| Assets. Invements in employer securities at end of year | 2021-09-30 | $891,807,419 |
| Assets. Invements in employer securities at beginning of year | 2021-09-30 | $0 |
| Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers | 2021-09-30 | $10,809,195 |
| Did the plan have assets held for investment | 2021-09-30 | Yes |
| Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser | 2021-09-30 | No |
| Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC | 2021-09-30 | No |
